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Purpose: Myocardial angiogenesis may improve regional perfusion and perhaps
function after cardiac injury. We evaluated the effect of endothelial cell transplan-
tation into a myocardial scar on angiogenesis and ventricular function, as an alter-
native to angiogenic gene or protein therapy.
Methods and Results: A transmural myocardial scar was created in the left ventric-
ular free wall of rat hearts by cryoinjury. Allogeneic aortic endothelial cells were
injected into the scar 2 weeks after cryoinjury. A cluster of transplanted cells was
identified at the site of injection 1 day and 1 week after transplantation, but not after
2 weeks. The size of this cluster of transplanted cells decreased as vascular density
in the transplanted scar tissue increased with time. Six weeks after transplantation,
vascular density was significantly greater in transplanted hearts than in control
hearts. Regional blood flow, by microsphere analysis, was greater in the trans-
planted rats. Systolic and diastolic ventricular function was similar between groups.
In a second series of experiments, syngeneic aortic endothelial cells labeled with
bromodeoxyuridine were transplanted 2 weeks after cryoinjury. Vascular density in
the transplanted scar was greater than in controls. Labeled transplanted endothelial
cells were identified forming part of the newly developed blood vessels. No differ-
ence in vascular density was found between allogeneic and syngeneic cell trans-
plantation. Vascular endothelial growth factor was not expressed at greater levels in
the transplanted cells or the myocardial scar.
Conclusion: Transplanted endothelial cells stimulated angiogenesis, were incorpo-
rated into the new vessels, and increased regional perfusion in myocardial scar tis-
sue, but did not improve global function in this cryoinjury rat model.
An increasing number of patients are being referred for coronaryartery bypass surgery despite extensive atherosclerosis that pre-cludes complete revascularization.1 A variety of novel angiogenictherapies2-7 are being evaluated as adjuncts to bypass grafting oras sole therapies for patients who are not candidates for coronaryartery bypass. The goal of these interventions is to induce angio-
genesis and increase perfusion to ischemic regions of the heart that cannot be ade-
quately revascularized by conventional means. Transmyocardial laser
revascularization improves anginal symptoms, probably by inducing angiogene-
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sis.2,3 Vascular endothelial growth factor (VEGF) and basic
fibroblast growth factor have been given as protein therapy
or as gene therapy by transfection by naked DNA or with
adenoviral vectors.4-9 Growth factors have been given as a
direct injection, in biodegradable capsules or by trans-
catheter delivery. The limitations of growth factor therapy
include the risks of systemic effects inducing problematic
angiogenesis in the retina or the potentiation of growth and
metastasis of occult tumors. In addition, stability and
adverse response to transfection vectors may limit the ben-
efits of growth factor gene therapy.
Cell transplantation into an infarcted region was intended to
restore elasticity to the injured region and prevent cardiac thin-
ning and dilatation.10-13 Several types of cultured cells have
been transplanted into the normal and infarcted myocardium of
various species, and the survival of the cells has been con-
firmed with improvements in global and regional function.10-13
Menasché and colleagues13a recently reported the first clinical
case of skeletal myoblast transplantation into an infarct region
with return of regional function (American Heart Association,
New Orleans, Louisiana, November 14, 2000). The survival of
the transplanted cells in animals and the first clinical trial were
facilitated by a profuse angiogenesis induced in and around the
transplanted cells.10-13 However, transplantation of cells to
induce angiogenesis to an injured cardiac region has not been
reported. We investigated endothelial cell transplantation
because these cells may secrete a variety of vascular growth
factors and because they may also participate in capillary for-
mation. We hypothesized that transplanted endothelial cells
would improve perfusion in a myocardial scar. We evaluated
the magnitude of the angiogenesis induced by both allogeneic
and syngeneic endothelial cell transplantation and the effects of
transplantation on global left ventricular function.
Methods
Experimental Animals
All procedures performed on animals were approved by the Animal
Care Committee of the Toronto General Hospital. Animal studies
were performed in accordance with the “Guide for the Care and Use
of Laboratory Animals” prepared by the Institute of Laboratory
Animal Resources, National Research Council, and published by the
National Academy Press, revised 1996. Sprague-Dawley rats (male,
300-350 g, Charles River Canada Inc, Quebec, Canada) were used as
both recipients and donors for the allogeneic cell transplantation (n =
16) or media control (n = 15). Syngeneic Lewis rats were used for the
syngeneic cell transplantation (n = 10) or media transplantation with-
out cells (n = 8).
Cell Culture and Identification
Endothelial cells were isolated and cultured from rat aortas by the
methods of Jaffe and associates.15 Cultured cells were passaged twice
before transplantation. More than 95% of the cultured cells stained
positively with antibodies against factor VIII–related antigen, con-
firming the purity of the cell cultures.16
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Quantification of VEGF Protein Levels in Cultured Cells
and Scar Tissue
Endothelial cells (purity 95%) were cultured in serum-free medium
for 24 hours and the cells and the conditioned medium were sepa-
rately harvested for quantification of VEGF protein at the same time
that other culture dishes were being harvested for transplantation.
VEGF protein concentrations in serum-free medium, conditioned
medium (medium cultured with cells for 24 hours), and cultured cell
lysates were quantitated by enzyme-linked immunosorbent assay,
aliquots of VEGF protein at known concentrations being used as
standards for comparison. One week after syngeneic cell transplanta-
tion (experiment 2), the scar tissue from the transplanted (n = 6) and
media control (n = 6) groups was excised, homogenized, and soni-
cated. VEGF levels in the scar tissue were also quantitated. The data
were expressed as nanograms of VEGF per milligram of total protein.
Myocardial Scar Generation 
Rats were anesthetized with ketamine (20 mg/kg body weight, intra-
muscularly) and sodium pentobarbital (30 mg/kg body weight,
intraperitoneally). Anesthetized rats were intubated and their lungs
were ventilated with room air supplemented with oxygen and isoflu-
rane (0.2%-1.0%) with a Harvard ventilator (Harvard Apparatus, Inc,
Holliston, Mass).
Via a left thoracotomy, cryoinjury of the left ventricular free wall
was performed with an elliptical metal probe 8 × l0 mm in diameter
cooled to –190°C by immersion in liquid nitrogen.12 The probe was
applied to the left ventricular free wall for 1 minute and the procedure
was repeated 10 times, to the same area of the left ventricular free
wall, to ensure a transmural injury. Penlog XL (benzathine penicillin
G 150,000 U/mL and procaine penicillin G 150,000 U/mL; 1 mL/kg)
and buprenorphine hydrochloride (0.01 mg/kg) were given intramus-
cularly after surgery. Cryoinjured rats were randomly divided into
transplantation and control groups.
Endothelial Cell Transplantation
Cultured endothelial cells were passaged twice and transplanted into
rat hearts 2 weeks after cryoinjury. The cells were detached from the
culture dish with trypsin, centrifuged, and resuspended in culture
medium at a concentration of 1.0 × l06 cells/10 µL. Via a sternotomy,
the cell suspension (60 µL, 6 × 106 cells) was injected into the center
of the scar in the transplantation group with a tuberculin syringe and
the same volume of culture medium was injected into the scar in con-
trol rats. Antibiotics and analgesics were given as described above. In
the first study (experiment 1), in which allogeneic cells were trans-
planted, cyclosporine A (INN: ciclosporin; 15 mg · kg–1 · d–1) was
administered subcutaneously to both the allotransplantated and con-
trol groups.
Identification of Transplanted Endothelial Cells
One, 7, and 14 days after the transplantation (experiment 1), 2 ani-
mals from each of the allogeneic endothelial cell transplanted and
media control groups were put to death and their hearts were fixed
and sectioned. After staining with hematoxylin and eosin, a cluster
of transplanted cells could be easily identified in the center of the
otherwise nearly acellular, transmural myocardial scar.
In addition, in experiments in which syngeneic endothelial cells
were used (experiment 2), the cultured cells were incubated with
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bromodeoxyuridine (BrdU), to be incorporated into proliferating
cells to facilitate subsequent identification after transplantation.
Two days before transplantation, 25 µL of 0.4% BrdU solution was
added to 10 mL of culture medium in the 100-mm culture dishes
and incubated until transplantation. Immediately before cell trans-
plantation, a portion of the BrdU-labeled cells were fixed and
stained with an antibody against BrdU. The total number of cells
and the number of BrdU-positive cells per high-power field were
counted, and the percentage of cells labeled with BrdU was calcu-
lated. Approximately 60% of the endothelial cells had incorporated
BrdU after 48 hours, and the cultured cells were then harvested and
transplanted into syngeneic adult rats as described previously (n =
10). These syngeneic rats did not receive cyclosporine to prevent
immunorejection. Six weeks after transplantation, the animals
were put to death and monoclonal antibodies against BrdU were
used to localize the transplanted endothelial cells in the scar.17
The Journal of Thoracic and Cardiovascular Surgery • Volume 122, Number 5   965
Measurement of Myocardial Blood Flow
Six weeks after transplantation, blood flow to the normal and scar tis-
sue was measured with radionuclide-labeled microspheres.18 A sus-
pension of 57Co-labeled microspheres (5 µCi; New England Nuclear,
Boston, Mass) was infused into the aortic root of the isolated hearts.
The ventricle was dissected into normal tissue, scar, and border zone.
Each section was weighed and the radioactivity in each fraction was
measured with a gamma counter using a window of 110 to 138 KeV.
The ratio of counts per minute per milligram in the scar and in the
border zone was calculated as a percentage of values in the normal
myocardium.
Measurement of Vascular Density in Scar Tissue
Heart sections were processed as previously described.12 The vascu-
lar density within the scar was counted by an observer blinded to the
treatment group at 200× magnification. Five fields of each section
Figure 1. A, Phase contrast photomicrograph of cultured endothelial cells showing their typical “cobblestone”
appearance (40×). B, Photomicrograph of cultured endothelial cells (arrows) stained positively (dark brown) for
factor VIII–related antigen (400×).
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Figure 2. Photomicrographs (100×) of hematoxylin-eosin–stained rat myocardial scar (S) in hearts excised 1 day
(a, b), 1 week (c, d), and 2 weeks (e, f) after injection of culture medium (control, a, c, e,) or endothelial cells
(transplanted, b, d, f). A cluster of endothelial cells (TC) was observed at the transplantation site on days 1 (b)
and 7 (d), but not on day 14 (f). There was no difference in the number of capillaries (arrows) between the con-
trol and transplanted scar 1 day after transplantation (a, b), but capillary density was markedly increased by 7
(d) and 14 (f) days after endothelial cell transplantation compared with controls (c, e). Red blood cells are pres-
ent in the capillaries.
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were randomly selected and the vascular density was averaged and
expressed as number of blood vessels per field (0.6 mm2).
Measurement of Left Ventricular Remodeling
The epicardial and endocardial surfaces of the normal and scar tissue in
the left ventricular free wall were measured as described previously.12
Evaluation of Ventricular Function
Six weeks after transplantation, left ventricular function was mea-
sured in a Langendorff preparation as we have previously
described.12
Statistical Analysis
Data were expressed as the mean ± standard deviation and ana-
lyzed with SAS software (SAS Institute, Inc, Cary, NC). Between-
group comparisons were performed with the Student t test. Left
ventricular function was evaluated by analysis of covariance.
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Results
Experiment 1: Allotransplantation With Cyclosporine
Administration
Cultured endothelial cells were distinguished from fibro-
blasts and vascular smooth muscle cells by morphologic cri-
teria, growth characteristics, and immunohistochemistry.
The endothelial cells were oval, in distinction to the spindle-
shaped fibroblasts and vascular smooth muscle cells, and
grew in a typical cobblestone appearance distinct from the
“whirling” pattern of fibroblasts and the “hill and valley”
pattern of vascular smooth muscle cells (Figure 1, A). The
endothelial cells stained positively for factor VIII–related
antigen (Figure 1, B). The purity of all endothelial cell cul-
tures used for transplantation was greater than 95%.
Two rats in the allotransplanted group were each put to
death 1, 7, and 14 days after transplantation to identify the
Figure 3. Photomicrographs of control (A) and endothelial cell transplanted (B) myocardial scar 6 weeks after
transplantation, stained for factor VIII–related antigen. Endothelial cells in the capillaries stained positively
(arrows, 100×). A greater number of blood vessels was observed in the transplanted group than in controls.
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transplanted cells within the scar. One day after transplanta-
tion, a large cluster of endothelial cells was observed within
the scar in the transplanted rats (Figure 2, b), but not in the
control rats (Figure 2, a). At 1 day, there was no increase in
vascular density in the scar around the cluster of trans-
planted endothelial cells compared with the controls. One
week after transplantation, blood vessels, mainly capillaries
and postcapillary venules, were noted in the scar near the
cluster of transplanted endothelial cells (Figure 2, d), but no
corresponding angiogenesis was noted in the control rats
(Figure 2, c). Over the week after transplantation, the clus-
ter of transplanted endothelial cells had diminished in size
as the number of blood vessels surrounding it had increased.
Two weeks after transplantation, the vascular density within
the scar of transplanted rats was greater than that in controls
(Figure 2, e and f) and the cluster of transplanted endothe-
lial cells had completely disappeared.
Six weeks after transplantation, vascular structures in
myocardial scar tissue were identified by staining the vas-
cular endothelial cells with antibody against factor VIII
(Figure 3). Vascular density in the transplanted scar (9.6 ±
5.5 vessels per 0.6 mm, n = 10) was greater (P = .002) than
that in the control scar (2.7 ± 1.8 vessels per 0.6 mm, n = 9)
(Figure 4). The blood vessels were more numerous in the
periphery of the scar than in the center. Six weeks after
transplantation, regional perfusion by microsphere measure-
ments was similarly increased in the transplanted group
(6.85% ± 2.27% of normal myocardium, n = 9) compared to
the control group (3.78 ± 0.99%, n = 8) (P = .008).
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Experiment 2: Syngeneic Transplantation Without
Cyclosporine Administration
Although there was no mononuclear cell infiltration indica-
tive of rejection in the allotransplanted animals treated with
cyclosporine A, we also transplanted syngeneic animals with
syngeneic endothelial cells to eliminate inflammation related
to rejection as a possible cause of angiogenesis. BrdU-
labeled syngeneic endothelial cells were transplanted into
the cryoinjury-induced myocardial scar tissue of adult rats.
Six weeks after transplantation, no leukocyte infiltration or
other evidence of inflammation was observed in the myocar-
dial scar. Many endothelial cells in the blood vessels in the
scar stained positively for BrdU, indicating that the trans-
planted BrdU-labeled endothelial cells had been incorpo-
rated into the newly formed blood vessels (Figure 5).
Vascular density in the scar tissue of the syngeneic trans-
planted group (7.5 ± 5.1 vessels per 0.6 mm2, n = 10) was
greater (P = .03) than that in the control group (2.9 ± 2.0 ves-
sels per 0.6 mm2, n = 8). No differences in vascular density
was found between allogeneic cell transplantation with
immunosuppression (9.6 ± 5.5 vessels per 0.6 mm2) and syn-
geneic cell transplantation (7.5 ± 5.1 vessels per 0.6 mm2).
One potential mechanism of angiogenesis was evaluated
by measuring VEGF levels in cultured cells in vitro and
myocardial scar tissue in vivo 1 week after transplantation.
The concentration of VEGF in conditioned medium, in
which cells had been incubated for 24 hours, was not differ-
ent from that in unconditioned medium. Lysates of cultured
cells contained 4.1 ± 1.4 ng of VEGF per milligram of total
protein (n = 7). VEGF concentrations in the transplanted
scar were 16.2 ± 5.1 ng of VEGF per milligram of total pro-
tein (n = 6) and were not different from controls (19.3 ± 7.4
ng of VEGF per milligram of total protein, n = 6).
In both the allotransplanted and syngeneically transplanted
rats, there were no differences in the weights of the hearts, left
ventricles, scar tissue, or body weights between the trans-
planted and control groups. Ventricular volume and scar size
were also similar between the transplanted and control groups.
There were also no differences in systolic, end-diastolic, or
developed pressures between transplanted and control hearts
(Figure 6). There were no significant differences in total coro-
nary blood flow and heart rate between groups.
Discussion
The limitations of current strategies of inducing angiogenesis
in the infarcted or ischemic myocardium that cannot be revas-
cularized by standard methods led us to explore cell trans-
plantation to stimulate neovascularization. In previous
studies, we demonstrated that transplantation of cardiomy-
ocytes12 and smooth muscle cells19 into a myocardial scar can
alter the postinjury remodeling process and improve global
left ventricular function. Accompanying these changes in
ventricular function, we noted a modest degree of angiogen-
esis.20 Therefore, we undertook a series of experiments to
Figure 4. Vascular density 6 weeks after allogeneic and syngeneic
endothelial cell transplantation. Capillary densities resulting from
either allogeneic or syngeneic endothelial cell transplantation
were significantly higher (P = .002 and P = .04, respectively) than
those in control rats. Capillary density in the allogeneic trans-
plantation group was not significantly different from that in the
syngeneic transplantation group.
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define the potential for cell transplantation to induce angio-
genesis for patients with extensive coronary atherosclerosis
who cannot be adequately revascularized. We selected
endothelial cells to be transplanted, speculating that this cell
type might participate in creating the capillary structure nec-
essary for angiogenesis. These cells may also secrete a vari-
ety of growth factors that could stimulate a profuse vascular
network. In addition, we compared the transplantation of allo-
geneic and syngeneic endothelial cells to determine the
effects of immune rejection on angiogenesis.5
We used a rat model of cryoinjury,12,19 which provides an
extreme challenge for any angiogenesis therapy. If cell trans-
plantation induces angiogenesis in this extreme model, then
treatment in an infarct model should be even more beneficial.
Cell transplantation was delayed until 2 weeks after myocar-
dial cryoinjury to avoid loss of the transplanted cells in the post-
necrosis inflammatory process. Preliminary studies suggested
that cells transplanted immediately or 7 days after cryoinjury
were eliminated by an intense inflammatory reaction.
In this study, we used an ex vivo technique of microsphere
injection to quantitate regional myocardial blood flow but
avoided the contribution of noncoronary collaterals. Injection
of microspheres into the left atrium or left ventricle in vivo
may more closely approximate physiologic regional blood
flows but may result in the majority of microspheres being
delivered into the systemic, noncardiac capillaries, as well as
permitting contamination of coronary blood flow by flow
through the vascular pericardial adhesions resulting from the
prior surgical procedures. Ex vivo microsphere injection in an
isolated heart allowed us to maximize the delivery of micro-
spheres into the myocardium, as well as to isolate the effect of
intramyocardial collateral formation caused by cell transplan-
tation from that of epicardial collaterals resulting from opera-
tive trauma. With this technique, we noted excellent mixing of
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Figure 5. Photomicrograph (400×) of BrdU-labeled cells transplanted into the myocardial scar. The scar was
stained 6 weeks after transplantation, using hematoxylin and antibodies against BrdU. Some endothelial cells
in both the large (A) and small (B) blood vessels stained positively (brown colored nuclei, arrows), indicating
that some of the transplanted endothelial cells were incorporated into the newly formed capillaries.
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the microspheres in the aortic root during retrograde
Langendorff perfusion and good reproducibility with low vari-
ability in our measurements of regional blood flow.
The microsphere data demonstrated increased regional per-
fusion in the scar area. The histologic studies also demon-
strated increased vascular density in the scar region. However,
no difference in perfusion of the myocardium outside the scar
would be anticipated. The increase in perfusion within the
scar, although statistically significant, would have been impos-
sible to distinguish in the vastly greater volume of total coro-
nary effluent measured in the Langendorff apparatus, which
was not different between groups.
Endothelial cell transplantation resulted in significantly
greater angiogenesis, identified by immunohistochemical
staining for factor VIII, evaluated by vascular density and
regional blood flow by microsphere injection, than control ani-
mals injected with culture medium alone. Vascular density
was approximately 3-fold greater in the transplanted rats than
in control animals, but regional blood flow was increased only
marginally from 3.8% to 6.9% of normalized values. This
improvement represents a doubling or tripling of the values
noted in control rats, but our model of cryoinjury may still
have limited the degree of angiogenesis achievable with
endothelial cell transplantation. A coronary ligation model of
myocardial infarction, in which a more extensive peri-infarct
border zone could harbor viable but hypoperfused cardiomy-
ocytes and endothelial cells, might result in greater angiogen-
esis. In addition, chronically ischemic cardiomyocytes in a
peri-infarct penumbra may secrete signaling factors that
potentiate the effect of the transplanted cells.
Potential mechanisms by which angiogenesis may be
induced after endothelial cell transplantation include the
following: (1) formation of blood vessels by transplanted
endothelial cells; (2) stimulation of angiogenesis by growth
factors expressed or stimulated by the transplanted endothe-
lial cells; and (3) stimulation of angiogenesis by an inflam-
matory reaction caused by the transplanted endothelial cells.
The hypothesis that transplanted endothelial cells may play
a structural role in induction of neovascularization is sup-
ported by the observation that many BrdU-labeled endothelial
cells were noted in the newly formed blood vessels 6 weeks
after transplantation. It is possible that a low level of unincor-
porated cytoplasmic BrdU may have remained in the endothe-
lial cells and that this BrdU may have been available for
uptake by native cells. However, because the BrdU incorpo-
rated into DNA must compete with non-BrdU labeled uridine
in the cytoplasm, cells must be incubated with high levels of
BrdU to be labeled effectively. The very low levels of BrdU
that might have diffused from the transplanted endothelial
cells into the interstitium of the myocardial scar would be
unlikely to have been sufficient to label the native cells. After
sectioning of the transplanted rat hearts, we noted a moderate
number of cells that stained intensely positive, surrounded by
unstained cells, consistent with BrdU being retained in the
transplanted endothelial cells, rather than a larger number of
weakly positive cells, a pattern that might be more consistent
with leakage of BrdU from the transplanted cells and uptake
by the surrounding native cells. Therefore, the BrdU-labeled
capillary cells were likely to have resulted from cell transplan-
tation rather than labeling of native cells after cell transplanta-
tion. These results are in agreement with data reported by
other investigators, who have also demonstrated incorporation
of endothelial cells into newly formed blood vessels in non-
cardiac tissues.21-24
We found no difference in VEGF protein levels between
the transplanted and control hearts. This finding may be
explained by the hypothesis that the angiogenesis induced by
endothelial cell transplantation is independent of changes in
VEGF expression. Alternatively, VEGF expression may have
been upregulated, but to a degree that was not detectable by
the relatively gross evaluation of total tissue levels by our
enzyme-linked immunosorbent assay technique. We would
speculate that even relatively low-level upregulation of VEGF
expression in the transplanted hearts may exert significant
effects on local angiogenesis, by autocrine or paracrine mech-
anisms. However, this hypothesis cannot be proved or dis-
proved by our current study.
Inflammation may induce angiogenesis by release of
cytokines and other mediators. However, no histologic evi-
dence of inflammation was noted either in the hearts of rats
transplanted with allogeneic endothelial cells (and given
cyclosporine) or in those of rats transplanted with syngeneic
endothelial cells (without cyclosporine). There was no sig-
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Figure 6. Developed pressures of the transplanted and control hearts
measured in a Langendorff preparation over a range of intraventric-
ular balloon volumes. There was no difference in developed pres-
sures between the transplanted and control groups. The
angiogenesis induced by endothelial cell transplantation did not
improve the function of hearts with a transmural scar.
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nificant difference in vascular density after allogeneic ver-
sus syngeneic transplantation, suggesting that rejection did
not affect angiogenesis in this series of experiments. A non-
specific inflammatory response may result from the
mechanical trauma of injection into the myocardial scar, but
this should also occur in the control rats, in which culture
medium without cells was injected. Our results suggest that
the transplanted endothelial cells participated in the forma-
tion of new blood vessels.
The increased perfusion noted after endothelial cell trans-
plantation did not affect ventricular remodeling or improve
global left ventricular function in our experimental model.
Previous studies with muscle cells (heart cells, smooth muscle
cells, or skeletal muscle myoblasts) demonstrated improved
global and regional function.11,13,19 The cells prevented car-
diac thinning and dilatation, improved systolic function, and
developed pressures at any ventricular volume. In contrast,
previous studies with nonmuscle cells (fibroblasts) did not
show an improvement in either global or regional function.
The elastic elements of the muscle cells may be necessary to
modify remodeling and prevent thinning and dilatation.
Increasing blood flow by endothelial cell transplantation in
this model did not improve contractility or prevent ventricular
dilatation. These data suggest that angiogenesis alone, without
restoration of cardiomyocyte numbers, will have less benefits
in patients with extensive, transmural myocardial infarctions.
We plan to perform autologous endothelial cell transplanta-
tion in our clinically relevant porcine model of occlusion of
the left anterior descending coronary artery.13 We anticipate
that angiogenesis may improve regional and global function.
Endothelial cell transplantation may become an alternative
to gene and protein therapy to induce angiogenesis in patients
who cannot be adequately revascularized by standard tech-
niques. Short segments of peripheral vein can be taken from
patients under local anesthesia, the endothelial cells isolated,
expanded in culture, and then transplanted into a cardiac
infarct region without the need for immunosuppression.
Endothelial cells transplanted into a nontransmural myocar-
dial infarction or into hibernating myocardium may improve
myocardial function by improving regional perfusion. Cell
transplantation may also be the ideal vehicle for therapeutic
gene transfer.26 The full potential of cell transplantation, how-
ever, remains to be clarified.
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